Faculty
Oncology Division
Alphabetical list (active faculty):   
Melissa A. Reimers

Melissa A. Reimers, MD

Assistant Professor

Department of Medicine

Oncology Division

Medical Oncology

Clinical Interests

  • Prostate cancer
  • Bladder cancer
  • Kidney cancer

Research Interests

  • Clinical trial development
  • Precision medicine
  • Immunotherapy

Contact

  • 314-747-7401 (office)
  • Division of Oncology
    Mail Stop 8056-0029-11
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • Room 11605 Mid Campus Center (office)

Peer-reviewed Publications

  • Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors
    Chen K, Shields MD, Chauhan PS, Ramirez RJ, Harris PK, Reimers MA, Zevallos JP, Davis AA, Pellini B, Chaudhuri AA
    Mol Diagn Ther 2021 Nov 1; [Epub ahead of print]
  • Urine- and Plasma-Based Detection of Minimal Residual Disease in Localized Bladder Cancer Patients
    Chen K, Chauhan PS, Babbra RK, Feng W, Pejovic N, Harris PK, Dienstbach K, Atkocius A, Maguire L, Qaium F, Huang Y, Szymanski J, Baumann BC, Ding L, Cao D, Reimers M, Kim E, Smith Z, Arora V, Chaudhuri AA
    Int J Radiat Oncol Biol Phys 2021 Nov 1;111(3S):e258-e259
  • Urine Tumor DNA Detection of Minimal Residual Disease in Muscle-Invasive Bladder Cancer Treated With Curative-Intent Radical Cystectomy: A Cohort Study
    Chauhan PS, Chen K, Babbra RK, Feng W, Pejovic N, Nallicheri A, Harris PK, Dienstbach K, Atkocius A, Maguire L, Qaium F, Szymanski JJ, Baumann BC, Ding L, Cao D, Reimers MA, Kim EH, Smith ZL, Arora VK, Chaudhuri AA
    PLoS Med 2021 Aug 31;18(8):e1003732
  • Cardiovascular Events in Men With Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS)
    Zhang KW, Reimers MA, Calaway AC, Fradley MG, Ponsky L, Garcia JA, Cullen J, Baumann BC, Addison D, Campbell CM, Ghosh AK, Lenihan DJ, Desai NR, Weintraub N, Guha A
    J Urol 2021 Sep;206(3):613-622
  • Differential Treatment Outcomes in BRCA1/2-, CDK12-, and ATM-Mutated Metastatic Castration-Resistant Prostate Cancer
    Kwon DH, Chou J, Yip SM, Reimers MA, Zhang L, Wright F, Dhawan MS, Borno HT, Desai A, Aggarwal RR, Wyatt AW, Small EJ, Alva AS, Chi KN, Feng FY, Koshkin VS
    Cancer 2021 Jun 15;127(12):1965-1973
  • Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy
    Fischer-Valuck BW, Michalski JM, Harton JG, Birtle A, Christodouleas JP, Efstathiou JA, Arora VK, Kim EH, Knoche EM, Pachynski RK, Picus J, Rao YJ, Reimers M, Roth BJ, Sargos P, Smith ZL, Zaghloul MS, Gay HA, Patel SA, Baumann BC
    Clin Genitourin Cancer 2021 Feb;19(1):41-46
  • Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma
    Reimers MA, Figenshau RS, Kim EH, Tucker J, Kasten N, Khan AS, Hanneken JM, Smith ZL, Hsieh JJ
    Clin Genitourin Cancer 2020 Oct;18(5):361-366
  • Clinical Outcomes in Cyclin-Dependent Kinase 12 Mutant Advanced Prostate Cancer
    Reimers MA, Yip SM, Zhang L, Cieslik M, Dhawan M, Montgomery B, Wyatt AW, Chi KN, Small EJ, Chinnaiyan AM, Alva AS, Feng FY, Chou J
    Eur Urol 2020 Mar;77(3):333-341
  • Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
    Reimers MA, Shango MM, Daignault-Newton S, Dedinsky R, Karsies D, Kraft S, Riddle L, Felton JA, Wen B, Gersch C, Rae JM, Redman BG, Alva AS
    Invest New Drugs 2019 Apr;37(2):323-330
  • Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
    Wu YM, Cieslik M, Lonigro RJ, Vats P, Reimers MA, Cao X, Ning Y, Wang L, Kunju LP, de Sarkar N, Heath EI, Chou J, Feng FY, Nelson PS, de Bono JS, Zou W, Montgomery B, Alva A, Robinson DR, Chinnaiyan AM
    Cell 2018 Jun 14;173(7):1770-1782e14
  • Hospice Utilization and Its Effect on Acute Care Needs at the End of Life in Medicare Beneficiaries With Hepatocellular Carcinoma
    Sanoff HK, Chang Y, Reimers M, Lund JL
    J Oncol Pract 2017 Mar;13(3):e197-e206
  • NOD2 Status and Human Ileal Gene Expression
    Hamm CM*, Reimers MA*, McCullough CK, Gorbe EB, Lu J, Gu CC, Li E, Dieckgraefe BK, Gong Q, Stappenbeck TS, Stone CD, Dietz DW, Hunt SR (*contributed equally)
    Inflamm Bowel Dis 2010 Oct;16(10):1649-57

Reviews, Chapters and Editorials

  • Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
    Bansal D, Reimers MA, Knoche EM, Pachynski RK
    Cancers (Basel) 2021 Jan 18;13(2)
  • Testicular Cancer and Germ Cell Tumors
    Reimers MA
    In: The Washington Manual of Oncology, 4th Edition (Morgensztern D, Ghobadi A, Govindan R, Editors), Wolters Kluwer, Philadelphia, 2022
  • Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: Past and Future Strategies for Optimization
    Reimers MA, Slane KE, Pachynski RK
    Curr Urol Rep 2019 Sep 3;20(10):64
  • Use of Bone-Modifying Agents in Myeloma and Bone Metastases: How Recent Dosing Interval Studies Have Affected Our Practice
    Campagnaro E, Reimers MA, Qin A, Alva AS, Schneider BJ, Van Poznak CH
    J Oncol Pract 2018 Aug;14(8):457-464